Capillary Electrophoresis Method Identifies Potential Antidepressant Compounds in Human Serum

Recently, a research team from the Medical University of Warsaw explored new 4-aryl-pyrido[1,2-c]pyrimidine derivatives in serum using a novel capillary electrophoresis (CE) method, with the hope that these derivatives could serve as potential antidepressant agents. The research team, led by Błażej Grodner, presented in their findings how their CE method advances pharmaceutical research by addressing one of the most common mental illnesses that afflict thousands of people (1). The findings were published in Chromatographia (1).

Antidepressant medications are designed to help people with symptoms of clinical depression. They can be divided into four classes: tricyclic antidepressants; monoamine oxidase inhibitors (MAOIs); serotonin reuptake inhibitors (SSRIs); and atypical antidepressants (2). In their study, the research team sought to uncover potential new agent compounds that could be used for antidepressant medications.

The derivatives the team discovered feature a conformationally restricted tryptamine moiety in their pharmacophore portion, showcasing high affinity towards molecular targets like the 5-HT1A receptor and serotonin transporter protein (1). The study outlines a meticulous separation process employing an eCAP fused-silica capillary, with detection wavelength set at 214 nm, buffered with 200 mM phosphate buffer at pH 8.0, operated at 20 °C, and applying a voltage of 5 kV (1).

The research team found great success in their CE method. It demonstrated exceptional reliability and precision, with a validated linearity spanning from 200 to 1000 ng/mL concentration range for all five derivatives (1). Notably, the method exhibited an impressive coefficient of determination (R²) ranging from 0.9978 to 0.9999 and a limit of quantification (LOQ) level between 287.1 to 310.1 ng/mL, ensuring robust quantification capabilities (1). Recoveries for all derivatives were found to be within the range of 94.7–100% (1).

This method differs from previous CE methods because of its ability to conduct chemical analysis rapidly. The method the researchers used was able to generate results in approximately 3 min, outstripping analysis times of previous methods (1). This speed coupled with its accuracy and reliability positions it as a frontrunner in the field of antidepressant compound identification (1). The study also highlights the method's versatility, allowing for the determination of these derivatives not only in water solutions but also in serum, a critical advancement in pharmacological research.

The developed CE method is unique in that it can isolate and determine antidepressant compounds in human serum (1). The method's efficacy is underscored by its ability to reliably quantify compounds I, II, III, IV, and V within the specified LOQ range of 167.1–186.1 ng/mL (1).

With its low intra- and inter-day precision, not exceeding 6% for all compounds, the CE method showcases its potential for widespread application in pharmaceutical research.

This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.

References

1. Grodner, B.; Król, M.; Ślifirski, G.; et al. Determination of New 4-Aryl-pyrido[1,2-c]pyrimidine Derivatives, Potential Antidepressant Agents with a High Affinity to 5-Hydroxytryptamin 1A Receptor and Serotonin Transporter Protein Receptor, with Capillary Electrophoresis. Chromatographia 2024, 87, 117–124. DOI: 10.1007/s10337-023-04300-0
2. Mandal, A. What are Antidepressants? Available at: https://www.news-medical.net/health/What-are-Antidepressants.aspx (accessed 02-27-2024).